It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Soliqua 100/33 (insulin glargine/lixisenatide) is a brand-name injection pen that’s prescribed to improve blood sugar levels in adults with type 2 diabetes. The drug’s cost, with and without ...

Ozempic is the brand name for a medicine called semaglutide ... Ozempic bumps up the release of insulin from the pancreas whenever blood sugar levels rise. Insulin helps the body use sugar ...

In the case of insulin, if the generic is covered ... sometimes in place of a brand-name. These insulins fall into different categories, such as generic, unbranded and biosimilar.

Citation: New type of insulin that switches on and off could help diabetics avoid sudden drops in blood sugar levels (2024, October 16) retrieved 11 November 2024 from https://medicalxpress.com ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Wright and other advocates for diabetes patients who need insulin to survive worry the nation's supply has become unreliable. Certain brands of insulin have been in shortage multiple times since ...

Ozempic is a brand-name semaglutide injection—a prescription ... which prompt the body to release more insulin in response to elevated blood glucose levels. However, semaglutide also slows ...

The Ayush Ministry, however, found that the manufacturer was labelling the product as a brand name and indicating its composition saying “Each tablet of 400 mg contains Insulin 6x”.